Right ventricular (RV) pacing can impair left ventricular (LV) function. When timed with native RV activation, LV-only pacing may cause greater improvements in LV function than biventricular pacing. This study compared the chronic effects of cardiac resynchronization therapy (CRT) on LV mechanics between biventricular pacing and LV-only pacing in patients with normal atrioventricular (AV) 
Introduction
Right ventricular (RV) pacing can negatively impact left ventricular (LV) function, especially in patients with reduced systolic function.
1 -3 Some negative consequences of RV pacing are also evident during biventricular pacing, especially dysfunction near the apex and within the interventricular septum. 4 -7 Although cardiac resynchronization therapy (CRT) utilizing biventricular pacing has become a well-established treatment for heart failure (HF) patients with low LV ejection fractions (LVEF) and conduction abnormalities, 8, 9 it is possible that LV-only pacing with intrinsic RV activation may result in greater improvements in cardiac function. Several studies have demonstrated that LV-only pacing is non-inferior to biventricular pacing in HF patients indicated to receive CRT.
10 -14 Smaller studies have also suggested that LV-only pacing, when timed to coincide with native RV activation, may result in more synchronous electrical activation and superior RV 15, 16 and LV 17,18 function compared with biventricular pacing. The Adaptive CRT (aCRT) algorithm (Medtronic, Inc., Mounds View, MN, USA) adjusts pacing parameters based on periodically measured intrinsic conduction intervals and provides LV-only pacing when the atrioventricular (AV) interval is normal. Device parameters synchronize the paced LV activation with the intrinsic RV activation. In a multi-centre, double-blind, randomized controlled trial, aCRT was shown to be safe and at least as effective as biventricular pacing with echocardiographic optimization. 19 Subsequent analyses have demonstrated that aCRT, when compared with biventricular CRT, reduced 30-day readmissions after HF hospitalizations during the study, 20 reduced the rate of HF hospitalization or death, and improved a clinical composite score in patients with normal AV conduction. 21 However, the effects of aCRT on the contractile function of the left ventricle have not been previously investigated.
We utilized echocardiograms collected during the aCRT trial to measure regional strain throughout the left ventricle. The primary objective of this study was to examine the differences in regional LV function between biventricular pacing and LV-only pacing prescribed by the aCRT algorithm in HF patients with normal AV conduction.
Methods

Patient population
Study design and primary results of the aCRT trial have been previously reported. 19, 22 Briefly, patients indicated for a CRT defibrillator, without permanent atrial fibrillation, were enrolled and randomized in a 2:1 ratio to receive either aCRT pacing or biventricular pacing with echocardiographic optimization. Details of the aCRT pacing algorithm have been previously described. 22 Importantly, when conduction from the right atrium to the right ventricle occurs normally (AV interval ≤200 ms during sinus rhythm, or ≤250 ms during atrial pacing) and the heart rate is ≤100 b.p.m., then LV-only pacing, which is timed to achieve LV pre-excitation, is delivered. In the control group of the aCRT study, biventricular pacing was delivered and the interventricular delay was echocardiographically optimized first to produce the greatest aortic velocity time integral (a surrogate of stroke volume AV delay was then optimized using the iterative method. 23 Clinical and echocardiographic follow-up was performed after 6 months of CRT, and every 6 months thereafter until the close of the study. The primary endpoint of the aCRT trial was the proportion of patients with an improvement in Packer's clinical composite score after 6 months of CRT. Overall, the aCRT trial demonstrated that the aCRT algorithm was non-inferior to echocardiographically optimized biventricular pacing. 19 We studied patients from the aCRT trial with normal AV conduction at their baseline visit, and compared global and regional LV function after 12 months of treatment between those randomized to biventricular pacing and those randomized to aCRT pacing who received ≥80% LV-only pacing over that period. The study was conducted in accordance with the Declaration of Helsinki, and local regulatory bodies and ethics committees. All patients signed informed consent documentation prior to enrolment in the study.
Echocardiography
Standard two-dimensional echocardiographic analysis was performed by a core laboratory as part of the aCRT study. LVEF and LV end-systolic volume (LVESV) were measured using Simpson's biplane method. Additional speckle tracking echocardiography analysis was performed to assess LV myocardial strain before and after treatment using vendor-independent software (2D Cardiac Performance Analysis, TomTec Imaging Systems, Untershleissheine, Germany). Radial LV strain was measured using parasternal short axis views of the mid-ventricle. Longitudinal LV strain was measured using apical four-chamber, two-chamber, and long-axis views. Representative images from the echocardiographic analysis in apical four-chamber views are shown in Figure 1 . Longitudinal peak strain at each level of the left ventricle (apical, mid-ventricular, and basal levels) was calculated as the mean of the peak strains for each wall segment (anterior, lateral, posterior, inferior, septal, and anteroseptal) at each level. Longitudinal peak strain of each wall was defined to be the mean peak strain measured at the apical, mid-ventricular, and basal levels. Global peak strain was defined as the mean value of the peak strains measured within each LV wall and at each level. In order to assess the function of the entire septal wall, the strain values from the septal and anteroseptal walls were averaged and compared with the mean strain from the opposing lateral and posterior walls. Intraventricular dyssynchrony was defined as the standard deviation of the time from QRS onset to peak systolic strain in each wall segment. Peak strain was defined as the largest positive value in the radial strain curve or the most negative point in the longitudinal strain curve.
Statistics
Continuous variables are reported as mean ± standard deviation and were compared using paired or unpaired Student's t-tests, as appropriate. Categorical variables are reported as number (percentage) and were compared between groups using the 2 test. Differences in all-cause mortality between groups were compared using Kaplan-Meier analysis and the log rank test. Survival analysis was conducted from the date of implant until the patient's death or the close of the study. Changes in echocardiographic variables between baseline and follow-up are reported as absolute differences. Between-group differences in changes in echocardiographic parameters at the 12-month follow-up were compared using a general estimating equation (GEE) population-averaged model with an exchangeable coefficient matrix. The blue arrows highlight the strain measured in the apical septum. Strain in this region is reduced following cardiac resynchronization therapy in the control patient, but is increased in the LV-only patient.
The GEE model was adjusted for gender, the presence of a left bundle branch block (LBBB), the presence of ischaemic disease, and baseline QRS duration. The intra-observer reproducibility of the strain measurements was assessed by re-analysing 38 randomly chosen echocardiograms. Bland-Altman analysis was performed and coefficients of variation were calculated with logarithmic transformations to normalize data. STATA/MP software version 14.2 (StataCorp, College Station, TX, USA) was used for data analysis and a two-sided P-value <0.05 was considered significant. Since this is a sub-analysis of a larger study that was neither designed nor powered to address the aims of this sub-study, no adjustments for multiple comparisons were made.
Results
Of the 318 treatment arm patients in the aCRT trial, 70 (22%) had a normal AV interval at the baseline visit and had received ≥80% LV-only pacing at their 1 year follow-up visit ( Figure 2 ). These patients made up the LV-only group for this sub-study. Compared with aCRT patients not meeting the sub-study criteria, patients in the LV-only group in our sub-study had a higher percentage of LBBB (87% vs. Within the biventricular-paced control group of the main aCRT study, similar differences were observed when comparing patients included in the biventricular-paced group for this sub-study ( Figure 2 ; n = 91) with those excluded due to prolonged AV conduction (n = 69). The control group patients with normal AV conduction were younger (64 ± 11 years vs. 70 ± 7 years, P < 0.001) and more frequently female (43% vs. 17%, P = 0.001), and they had greater improvements in EF [5 ± 10% vs. 1 ± 9% (EF units), P = 0.026] and LVESV (−39 ± 55 mL vs. −16 ± 36 mL, P = 0.012) than those with prolonged AV conduction. Patient demographic and baseline echocardiographic data for the two sub-study groups were well-matched, and are presented in Table 1 .
Of the 322 potential echocardiograms from these patients, 311 (97%) were available for analysis. A total of 24 sub-study patients were missing 12-month follow-up echocardiograms. Missing 12-month echocardiograms were a result of patient death in eight cases (six from the biventricular-paced group). Additionally, two follow-up echocardiograms were omitted because the heart rate was <100 b.p.m., so the patients could not have received LV-only pacing during the exam. One patient from the biventricular-paced Figure 2 Patient selection flowchart. The flowchart depicts the method by which patients from the main aCRT trial were selected for inclusion in this sub-study. The left ventricular (LV)-only-paced population for this sub-study included only patients from the aCRT arm of the main trial who received ≥80% LVonly pacing and had a normal atrioventricular (AV) interval at their baseline visit. Patients from the control arm of the main aCRT trial who had a normal AV interval at the baseline visit were included in the biventricular-paced control group. The groups represented by the shaded boxes are those included in this study. group was omitted from the analysis because a significant portion of beats were recorded as LV-only paced. In total, paired strain data could be measured in 126 subjects (78% of study patients). Mean follow-up time in these patients was 374 ± 21 days.
A random selection of 38 echocardiograms were re-analysed to assess intra-observer reproducibility. Mean longitudinal strain measurements showed a non-significant bias of 1.0%, with limits of agreement from −1.2 to 3.2%. The coefficient of variation was 4%. Repeated measurements of mean radial strain showed a nonsignificant bias of 1.1% and limits of agreement from −1.2 to 3.3%. The coefficient of variation between radial strain measurements was 10%.
The percentage of CRT responders was not significantly different between LV-only and biventricular pacing groups, whether identified by improvements in clinical composite score (77% vs. 66%, P = 0.204) or by echocardiographic criteria (change in LVESV ≥15%; 71% vs. 60%, P = 0.181). However, the LV-only pacing group tended to have a greater percentage of responders in both cases. The mortality rate was not significantly different between groups (mean follow-up time 1.7 ± 0.4 years; five deaths at 4.1% per year in the LV-only group vs. nine deaths at 5.9% per year in the biventricular-paced group, P = 0.532).
. Echocardiographic changes at follow-up are presented in Table 2 . Patients with LV-only pacing had greater improvements in LVEF than those randomized to biventricular pacing (absolute change: 8.5 ± 11.3% vs. 5.5 ± 10.3%, P = 0.038). This was mirrored by greater improvements in global radial strain (absolute change: 6.3 ± 8.6% vs. 4.0 ± 10.1%, P = 0.046) and a trend for greater improvements in global longitudinal strain (absolute change: −2.6 ± 3.9% vs. −1.6 ± 3.5%, P = 0.052) in the LV-only paced group.
Radial strain changes in the mid-LV level are presented in Figure 3A and B. There was a greater improvement in radial strain in the septal and anteroseptal walls in the LV-only pacing group than in the biventricular pacing group (absolute change: 7.7 ± 10.4% vs. 5.8 ± 12.1%, P = 0.049), but no difference in radial strain improvement of the lateral and posterior walls between the groups (4.1 ± 13.2% vs. 3.1 ± 14.9%, P = 0.564).
Changes in longitudinal strain in each of the six LV walls are presented in Figure 3C and D. Mean longitudinal strain of the septal and anteroseptal walls improved more in the LV-only pacing group than in the biventricular pacing group (absolute change: −4.2 ± 4.4% vs. −2.9 ± 4.0%, P = 0.015). The improvements in mean longitudinal strain within the lateral and posterior walls were also greater in the LV-only pacing group (absolute change: −1.6 ± 5.2% vs. −0.7 ± 4.7%, P = 0.049). Within each group, the improvement in strain was greater in the septal and anteroseptal walls than in the lateral and posterior walls (P < 0.001 for both biventricular and LV-only pacing groups). Regional longitudinal mechanics at three levels of the left ventricle are presented in Figure 4 . The improvement in the mean peak longitudinal strain measured at the apical level was greater in the LV-only pacing group than in the biventricular pacing group (absolute change: −4.4 ± 6.0% vs. −1.9 ± 6.1%, P = 0.039). In the LV-only paced group, mean peak longitudinal strain increased more in the apex than in the mid-LV (absolute change: −2.0 ± 4.3%, P = 0.010 vs. apex) or basal levels (absolute change: −1.9 ± 4.8%, P = 0.003 vs. apex). In the biventricular pacing group, longitudinal strain improved similarly among all three levels of the left ventricle.
Discussion
The primary finding of this study is that, in patients indicated for CRT with normal AV conduction, LV-only pacing delivered by the aCRT algorithm resulted in significantly greater improvement in EF than echocardiographically optimized biventricular pacing. This modest (3.8%) absolute difference in global LV function was associated with greater improvements in regional LV function at the apical level and within the septal and anteroseptal walls of the left ventricle. Since the RV lead is often located near the apical septum, the greater improvement in function in this region with LV-only pacing can most likely be attributed to the avoidance of RV pacing that occurs during biventricular pacing. As a result, LV-only pacing that is timed with intrinsic RV activation may result in a more effective myocardial activation sequence in these patients.
Left ventricular mechanics during right ventricular pacing
The increased risk of HF with RV pacing has been well established. the left ventricle and slowing activation. 26 The changes in electrical activation caused by RV pacing result in abnormal mechanical contraction patterns in the left ventricle, especially at the apex and the septal wall. 4 -6 In a canine study of RV pacing , Prinzen et al. demonstrated that regional LV function is altered with pacing, and that myocardial strain and work are most severely reduced near the pacing lead.
1 Early activation near the pacing site results in an inefficient contraction, and compensatory increases in strain and work in remote regions of the left ventricle. Studies have demonstrated that the magnitude of an abnormal leftward septal motion during the pre-ejection phase with RV pacing is a good predictor of the degree of LV dysfunction. 6 We have previously analysed regional deformation in humans and made similar observations. 4, 27 In particular, we found that in patients who are chronically paced from the RV apex, longitudinal displacement and strain frequently exhibit a paradoxical lengthening during early systole in the apical septal region of the left ventricle.
Left ventricular-only pacing for cardiac resynchronization therapy
Alterations in electrical activation and mechanical function of the right ventricle are similar whether it is paced alone, or in conjunction with the left ventricle. 15, 28 Although conventional CRT involves pacing both ventricles, the avoidance of RV pacing in these patients might yield improved outcomes.
In a simulation study of pacing in LBBB, Lumens et al. found that biventricular pacing and LV-only pacing yielded similar improvements in total myofibre work, despite differences in the distribution of work.
13 Specifically, the right ventricle and the septal wall generated more work during LV-only pacing than during biventricular pacing. Our results are in agreement with regard to differences in septal function between the two pacing modes, but differ with respect to other wall segments. This may be due to fundamental differences between simulated myofibre mechanics and echocardiographic findings from a cohort of patients. Also, the simulated results were based on a hypothetical patient with an AV delay of 220 ms during sinus rhythm, which is slightly longer than the maximum delay allowed for inclusion in this study. As a 11,29 quality of life, 11, 29 and mortality and hospitalization rates. 10 However, in these studies, patients were not generally selected based on the existence of normal AV conduction, and LV activation was not specifically timed to be synchronized with intrinsic RV conduction. These factors may contribute to the differences in LV contraction found in the current study.
Acute haemodynamic studies have demonstrated that, when optimally timed with intrinsic RV activation, LV-only pacing results in superior RV 16 and LV 18 function when compared with biventricular pacing. Our results extend these findings by demonstrating that, in selected patients, appropriately timed LV-only pacing results in greater chronic improvements in global and regional LV function measured by echocardiography.
Adaptive cardiac resynchronization therapy
The aCRT algorithm was developed to take advantage of the potential superiority of optimally timed LV-only pacing in patients with normal RV activation. The primary results of the multi-centre trial of aCRT demonstrated that it was safe and non-inferior to echocardiographically optimized biventricular pacing with regard to clinical composite score and aortic outflow velocity time integral.
19 Subsequent analyses have indicated that patients with ≥50% LV-only pacing had greater decreases in the risk of death from all causes or hospitalization for HF, a greater increase in clinical composite score, and a greater increase in LVEF than aCRT patients with less frequent LV-only pacing. 21 Since these studies suggest that LV-only pacing provides an important benefit when applied according to the aCRT algorithm, the objective of the current study was to investigate the . mechanical differences in LV contraction between chronic LV-only pacing and standard biventricular pacing in patients with normal AV conduction. Unlike the previous analyses of the aCRT trial, we did not find significant differences in rates of clinical or echocardiographic response, or in mortality rates, between the patients receiving aCRT and those receiving biventricular pacing. Since we did see trends for better response rates with aCRT, it is likely that our inclusion of only patients with normal AV intervals resulted in group sizes too small to detect differences. Additionally, patients with normal AV conduction may have been healthier at baseline, as a previous large registry study demonstrated that patients with pre-CRT PR intervals of ≥230 ms had a greater risk of HF hospitalization or death than those with short PR intervals. 30 Thus patients with normal AV conduction in our study could be less likely to exhibit improvements. In spite of the relatively small groups, we were able to find significant differences in the contraction patterns at the apical level of the left ventricle, and in the septal and anteroseptal regions of the left ventricle. These differences likely contributed to the greater improvements in LVEF in the predominantly LV-only paced group, and to the enhanced clinical responses found in previous analyses of the aCRT trial.
Limitations
The results of this study should be interpreted with caution due to a number of limitations. In order to test the effect of LV-only pacing with a reasonably large sample size, we selected patients from the primary aCRT trial with ≥80% LV-only paced beats. Thus some degree of biventricular pacing occurred in the group that represented LV-only pacing. This may have limited our ability to detect differences between groups. The frequency of biventricular pacing in the group receiving aCRT in this sub-study was only 7 ± 5%, so the effect on our results was likely to be small. In addition, patients with aCRT pacing received LV-only pacing only when intrinsic AV conduction was normal. There were significant differences between patients who received frequent LV-only pacing and those who did not. For this reason, we selected only patients from the control arm of the aCRT trial who also had normal AV conduction at their baseline visit. While this method resulted in groups that appeared well-matched, it is possible that some patients in the control group, due to variable AV conduction or frequent tachycardia, would not have received ≥80% LV-only pacing if they had been assigned to the aCRT arm of the main study. Additionally, LV leads were positioned according to the implanting physicians' preference in this study, and individualized optimal lead locations were not necessarily targeted. 31 ,32 While we found that lead locations were similar between biventricular and LV-only-paced groups, it is possible that our results may have been different if lead locations had been optimally selected. We also analysed the latest echocardiogram available for each patient. We have recently reported that echocardiographic evidence of positive CRT response can be delayed in a significant number of patients, 33 so our results may have differed with shorter, or longer, follow-up times. Furthermore, it is a recognized limitation that speckle tracking analysis requires adequate echocardiographic image quality and cannot be applied to all patients. Finally, the aCRT algorithm frequently adjusts pacing parameters based on device assessments of intrinsic conduction. Our results may not apply when LV-only pacing is delivered without these parameter adjustments.
Conclusions
In HF patients with normal AV conduction, pacing of the left ventricle alone with an algorithm that provides LV-only pacing timed with native RV activation results in greater improvements in LVEF, which are associated with better longitudinal function at the apex and within the septal and anteroseptal regions of the left ventricle. The avoidance of RV pacing in these patients, while not necessarily reducing mechanical dyssynchrony, most likely resulted in a more efficient LV activation sequence.
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